Shahriar Heidary, MD
Cardiovascular Disease (Cardiology) · Seattle
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sea Mar Community Health Centers · 235 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Heidary’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A82213 · Current
Licensed to practise in California · since 2003 · expires 2027-03-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$3,355
Medicare paid this office $3,355 for 30 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $2,559 | $135 |
Who their Medicare patients are
30 Original Medicare patients in 2024. Average age 66 · Women 37% · Also on Medicaid 53% · Health risk score 0.78. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 63% · Diabetes 37%.
The office billed $14,720, Medicare allowed $5,222 and paid $3,355; for 43 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 30 | 43 | 66 | 0.78 | $14,720 | $3,355 |
| 2023 | 39 | 81 | 72 | 1.19 | $26,076 | $6,326 |
| 2022 | 30 | 61 | 67 | 0.90 | $14,086 | $2,968 |
| 2021 | 36 | 100 | 70 | 0.99 | $18,602 | $5,097 |
| 2020 | 24 | 94 | 70 | 1.18 | $12,368 | $3,713 |
| 2019 | 14 | 51 | 70 | 0.81 | $7,646 | $1,972 |
| 2018 | 257 | 5,252 | 78 | 1.58 | $496,968 | $218,464 |
| 2017 | 266 | 4,652 | 78 | 1.51 | $476,067 | $190,198 |
| 2016 | 253 | 3,473 | 78 | 1.76 | $392,289 | $155,744 |
| 2015 | 329 | 5,062 | 79 | 1.70 | $533,659 | $192,719 |
| 2014 | 595 | 4,746 | 78 | 1.69 | $544,224 | $214,829 |
| 2013 | 649 | 3,066 | 78 | 1.70 | $208,577 | $157,223 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $5,139 | $143 |
2022: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 19 | $2,188 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $103 | $9 |
2021: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $3,574 | $170 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $157 | $10 |
2020: 1 service
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $2,149 | $179 |
2019: 1 service
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $93 | $8 |
2018: 15 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 50 | $80,240 | $1,543 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 47 | $37,195 | $380 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $30,674 | $207 |
| Return visit (30+ min) | 195 | $30,244 | $92 |
| Short return visit (20+ min) | 94 | $9,657 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 241 | $8,767 | $16 |
| New patient visit (45+ min) | 41 | $6,211 | $151 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $5,090 | $70 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 49 | $1,877 | None |
| Short return visit | 33 | $1,748 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 22 | $564 | $25 |
| Electrocardiogram (ecg) 2-day continuous | 21 | $519 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $412 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $223 | $17 |
| Infusion, normal saline solution, 250 cc | 37 | $137 | None |
2017: 15 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 44 | $63,839 | $1,451 |
| Return visit (30+ min) | 202 | $35,066 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $29,747 | $227 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 43 | $19,462 | $226 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 245 | $9,663 | $15 |
| Short return visit (20+ min) | 89 | $9,167 | $66 |
| New patient visit (45+ min) | 56 | $7,541 | $135 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 54 | $3,776 | $69 |
| Short return visit | 20 | $1,238 | $41 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 44 | $1,184 | None |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 30 | $792 | $24 |
| Electrocardiogram (ecg) 2-day continuous | 29 | $662 | $21 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 19 | $612 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 19 | $509 | $20 |
| Infusion, normal saline solution, 250 cc | 41 | $124 | None |
2016: 17 services
| Return visit (30+ min) | 198 | $38,179 | $90 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 24 | $35,840 | $1,434 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $29,324 | $222 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 24 | $11,557 | $231 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 232 | $9,844 | $15 |
| Short return visit (20+ min) | 91 | $8,764 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $6,738 | $91 |
| New patient visit (45+ min) | 31 | $4,453 | $144 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 26 | $2,127 | $73 |
| Short return visit | 24 | $1,372 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 40 | $986 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 40 | $965 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $860 | $57 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 23 | $823 | None |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $601 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 22 | $588 | $24 |
| Infusion, normal saline solution, 250 cc | 21 | $67 | None |
2015: 15 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 45 | $64,756 | $1,439 |
| Return visit (30+ min) | 194 | $35,121 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $31,348 | $156 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 45 | $20,315 | $226 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 223 | $9,137 | $15 |
| Short return visit (20+ min) | 76 | $7,227 | $66 |
| New patient visit (45+ min) | 43 | $6,277 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $4,769 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $3,717 | $73 |
| Short return visit | 41 | $2,277 | $39 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 45 | $2,003 | None |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 29 | $723 | $24 |
| Electrocardiogram (ecg) 2-day continuous | 29 | $673 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $271 | $19 |
| Infusion, normal saline solution, 250 cc | 45 | $108 | None |
2014: 20 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 42 | $61,195 | $1,457 |
| Return visit (30+ min) | 253 | $48,134 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 431 | $27,278 | $59 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 42 | $19,222 | $229 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 278 | $9,394 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $7,975 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 105 | $6,444 | $61 |
| New patient visit (45+ min) | 43 | $6,093 | $142 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 30 | $3,604 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 158 | $2,979 | $18 |
| Short return visit (20+ min) | 32 | $2,860 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,775 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 158 | $1,957 | $12 |
| Short return visit | 25 | $1,411 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,191 | $57 |
| Electrocardiogram (ecg) 2-day continuous | 39 | $1,072 | $27 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 39 | $946 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $313 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 12 | $305 | $25 |
| Infusion, normal saline solution, 250 cc | 30 | $65 | None |
2013: 12 services
| Return visit (30+ min) | 262 | $51,791 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 457 | $28,225 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $19,132 | $89 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 207 | $14,870 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 291 | $11,779 | $17 |
| Short return visit (20+ min) | 48 | $5,939 | $67 |
| New patient visit (45+ min) | 44 | $5,883 | $134 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 278 | $5,500 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 278 | $3,646 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $2,959 | $54 |
| Emergency department visit with moderate level of medical decision making | 12 | $1,153 | $96 |
| Short return visit | 14 | $628 | $42 |
Medicaid work
$12,723 in 2024
Medicaid paid $12,723 for 1,004 billed services this clinician did in 2024, up to 45 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 182 | $5,739 |
| Return visit (30+ min) | 89 | $3,273 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 38 | $3,212 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 13 | $499 |
| Medication list documented in medical record (COA) | 115 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 112 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 47 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 166 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 201 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 28 | $0 |
| 2024 | 1,004 | 11 | 45 | $12,723 |
| 2023 | 241 | 4 | 26 | $10,392 |
| 2022 | 43 | 2 | 17 | $1,444 |
| 2021 | 14 | 1 | 13 | $469 |
| 2020 | 16 | 1 | 12 | $187 |
| 2018 | 27 | 1 | 12 | $412 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 158 | $6,485 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 37 | $2,477 |
| Short return visit (20+ min) | 34 | $1,056 |
| Clinic visit/encounter, all-inclusive | 12 | $374 |
2022
| Short return visit (20+ min) | 30 | $905 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $538 |
2021
| Return visit (30+ min) | 14 | $469 |
2020
| Clinic visit/encounter, all-inclusive | 16 | $187 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 27 | $412 |
Drugs they prescribed that Part D paid
$154,549
Pharmacies billed $154,549 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 717) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
535 generic and 182 brand-name prescriptions · $154,549 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 62 | $52,616 | $849 |
| Eliquis | 31 | $35,297 | $1,139 |
| Entresto | 39 | $33,611 | $862 |
| Praluent | 11 | $7,220 | $656 |
| Metoprolol | 149 | $1,487 | $10 |
See all 19 drugs
| Xarelto | 62 | $52,616 | $849 |
| Eliquis | 31 | $35,297 | $1,139 |
| Entresto | 39 | $33,611 | $862 |
| Praluent | 11 | $7,220 | $656 |
| Metoprolol | 149 | $1,487 | $10 |
| Ezetimibe | 20 | $533 | $27 |
| Rosuvastatin | 49 | $531 | $11 |
| Carvedilol | 21 | $461 | $22 |
| Nitroglycerin | 29 | $384 | $13 |
| Atorvastatin | 39 | $361 | $9 |
| Furosemide | 43 | $224 | $5 |
| Amlodipine Besylate | 24 | $188 | $8 |
| Torsemide | 13 | $182 | $14 |
| Losartan | 27 | $156 | $6 |
| Clopidogrel | 12 | $137 | $11 |
| Isosorbide Mononitrate Er | 26 | $110 | $4 |
| Lisinopril | 18 | $63 | $4 |
| Pantoprazole | 11 | $35 | $3 |
| Potassium Chloride | 13 | $1 | $0 |
Year by year
| 2024 | 717 | 104 | 0% (0) | 25% | $154,549 |
| 2023 | 510 | 99 | 0% (0) | 22% | $90,805 |
| 2022 | 317 | 59 | 0% (0) | 25% | $59,021 |
| 2021 | 270 | 47 | 0% (0) | 27% | $42,484 |
| 2020 | 186 | 34 | 0% (0) | 19% | $17,812 |
| 2019 | 469 | 124 | 0% (0) | 18% | $62,238 |
| 2018 | 1,291 | 167 | 0% (0) | 18% | $167,399 |
| 2017 | 1,189 | 160 | 0% (0) | 21% | $113,565 |
| 2016 | 1,067 | 138 | 0% (0) | 27% | $110,611 |
| 2015 | 1,135 | 147 | 0% (0) | 33% | $113,257 |
| 2014 | 1,077 | 148 | 0% (0) | 36% | $85,188 |
| 2013 | 1,011 | 142 | 0% (0) | 39% | $72,658 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Xarelto | 39 | $35,783 | $918 |
| Entresto | 27 | $23,171 | $858 |
| Eliquis | 28 | $21,486 | $767 |
| Metoprolol | 100 | $2,145 | $21 |
| Atorvastatin | 45 | $837 | $19 |
| Rosuvastatin | 41 | $781 | $19 |
| Irbesartan | 13 | $492 | $38 |
| Ezetimibe | 12 | $377 | $31 |
| Nitroglycerin | 18 | $349 | $19 |
| Carvedilol | 20 | $343 | $17 |
| Clopidogrel | 16 | $232 | $14 |
| Amlodipine Besylate | 18 | $199 | $11 |
| Lisinopril | 20 | $142 | $7 |
| Furosemide | 22 | $118 | $5 |
2022: 9 drugs
| Entresto | 40 | $31,913 | $798 |
| Xarelto | 12 | $11,022 | $918 |
| Eliquis | 13 | $8,107 | $624 |
| Metoprolol | 59 | $859 | $15 |
| Atorvastatin | 34 | $561 | $16 |
| Rosuvastatin | 20 | $197 | $10 |
| Furosemide | 23 | $97 | $4 |
| Amlodipine Besylate | 18 | $90 | $5 |
| Carvedilol | 13 | $69 | $5 |
2021: 9 drugs
| Entresto | 33 | $22,855 | $693 |
| Rosuvastatin | 17 | $1,039 | $61 |
| Ezetimibe | 13 | $857 | $66 |
| Metoprolol | 30 | $662 | $22 |
| Atorvastatin | 45 | $418 | $9 |
| Nitroglycerin | 12 | $169 | $14 |
| Furosemide | 21 | $71 | $3 |
| Amlodipine Besylate | 12 | $64 | $5 |
| Clopidogrel | 11 | $49 | $4 |
2020: 6 drugs
| Eliquis | 15 | $9,079 | $605 |
| Metoprolol | 42 | $760 | $18 |
| Atorvastatin | 15 | $175 | $12 |
| Lisinopril | 13 | $157 | $12 |
| Metoprolol | 13 | $157 | $12 |
| Furosemide | 12 | $25 | $2 |
2019: 11 drugs
| Eliquis | 45 | $37,945 | $843 |
| Ezetimibe | 14 | $2,188 | $156 |
| Metoprolol | 74 | $2,143 | $29 |
| Atorvastatin | 43 | $634 | $15 |
| Pravastatin | 13 | $559 | $43 |
| Amlodipine Besylate | 52 | $502 | $10 |
| Losartan | 23 | $475 | $21 |
| Isosorbide Mononitrate Er | 11 | $249 | $23 |
| Lisinopril | 20 | $213 | $11 |
| Carvedilol | 13 | $97 | $7 |
| Hydrochlorothiazide | 13 | $67 | $5 |
2018: 26 drugs
| Eliquis | 74 | $70,377 | $951 |
| Ranexa | 34 | $24,581 | $723 |
| Ezetimibe | 49 | $10,287 | $210 |
| Bystolic | 38 | $9,866 | $260 |
| Xarelto | 15 | $9,835 | $656 |
| Metoprolol | 152 | $5,668 | $37 |
| Prasugrel | 13 | $4,930 | $379 |
| Rosuvastatin | 47 | $2,966 | $63 |
| Atorvastatin | 105 | $2,102 | $20 |
| Amlodipine Besylate | 153 | $1,519 | $10 |
| Pravastatin | 65 | $1,469 | $23 |
| Olmesartan Medoxomil | 14 | $1,429 | $102 |
| Benazepril-Hydrochlorothiazide | 12 | $1,125 | $94 |
| Isosorbide Mononitrate Er | 36 | $1,035 | $29 |
| Propafenone | 12 | $898 | $75 |
| Nitroglycerin | 37 | $852 | $23 |
| Losartan | 49 | $577 | $12 |
| Sotalol | 12 | $466 | $39 |
| Atenolol | 34 | $380 | $11 |
| Carvedilol | 47 | $379 | $8 |
| Potassium Chloride | 16 | $379 | $24 |
| Lisinopril | 32 | $373 | $12 |
| Metoprolol | 26 | $243 | $9 |
| Simvastatin | 24 | $204 | $8 |
| Furosemide | 31 | $204 | $7 |
| Hydrochlorothiazide | 16 | $163 | $10 |
2017: 26 drugs
| Eliquis | 28 | $25,615 | $915 |
| Ranexa | 44 | $23,468 | $533 |
| Xarelto | 18 | $12,034 | $669 |
| Ezetimibe | 38 | $9,110 | $240 |
| Bystolic | 18 | $5,556 | $309 |
| Metoprolol | 138 | $4,242 | $31 |
| Pravastatin | 85 | $2,385 | $28 |
| Rosuvastatin | 33 | $2,330 | $71 |
| Atorvastatin | 88 | $1,742 | $20 |
| Amlodipine Besylate | 118 | $1,253 | $11 |
| Benazepril-Hydrochlorothiazide | 12 | $1,119 | $93 |
| Isosorbide Mononitrate Er | 43 | $1,087 | $25 |
| Sotalol | 13 | $764 | $59 |
| Nitroglycerin | 29 | $654 | $23 |
| Valsartan | 13 | $595 | $46 |
| Potassium Chloride | 18 | $513 | $28 |
| Losartan | 42 | $465 | $11 |
| Hydralazine | 15 | $419 | $28 |
| Lisinopril | 29 | $372 | $13 |
| Furosemide | 46 | $313 | $7 |
| Carvedilol | 54 | $288 | $5 |
| Warfarin | 16 | $257 | $16 |
| Clopidogrel | 18 | $248 | $14 |
| Metoprolol | 44 | $236 | $5 |
| Atenolol | 33 | $200 | $6 |
| Simvastatin | 21 | $85 | $4 |
2016: 29 drugs
| Eliquis | 37 | $23,531 | $636 |
| Ranexa | 31 | $18,005 | $581 |
| Zetia | 36 | $15,898 | $442 |
| Xarelto | 11 | $6,657 | $605 |
| Crestor | 12 | $6,476 | $540 |
| Bystolic | 13 | $3,225 | $248 |
| Metoprolol | 105 | $2,646 | $25 |
| Atorvastatin | 71 | $2,093 | $29 |
| Valsartan | 20 | $1,912 | $96 |
| Amlodipine Besylate | 119 | $1,254 | $11 |
| Nitrostat | 34 | $1,163 | $34 |
| Rosuvastatin | 12 | $1,053 | $88 |
| Isosorbide Mononitrate Er | 37 | $1,038 | $28 |
| Pravastatin | 51 | $1,020 | $20 |
| Benazepril-Hydrochlorothiazide | 12 | $737 | $61 |
| Clopidogrel | 26 | $711 | $27 |
| Sotalol | 11 | $537 | $49 |
| Hydralazine | 33 | $448 | $14 |
| Losartan | 23 | $430 | $19 |
| Diltiazem | 15 | $386 | $26 |
| Warfarin | 36 | $370 | $10 |
| Carvedilol | 47 | $359 | $8 |
| Potassium Chloride | 18 | $356 | $20 |
| Lisinopril | 25 | $351 | $14 |
| Furosemide | 28 | $152 | $5 |
| Atenolol | 20 | $147 | $7 |
| Simvastatin | 18 | $106 | $6 |
| Pantoprazole | 13 | $103 | $8 |
| Metoprolol | 14 | $64 | $5 |
2015: 29 drugs
| Ranexa | 46 | $26,936 | $586 |
| Eliquis | 36 | $16,477 | $458 |
| Zetia | 36 | $11,783 | $327 |
| Xarelto | 13 | $7,403 | $569 |
| Crestor | 17 | $6,997 | $412 |
| Valsartan | 18 | $2,891 | $161 |
| Diltiazem 24hr Er | 16 | $2,550 | $159 |
| Metoprolol | 77 | $2,523 | $33 |
| Atorvastatin | 75 | $1,980 | $26 |
| Isosorbide Mononitrate Er | 59 | $1,243 | $21 |
| Pravastatin | 32 | $1,018 | $32 |
| Benazepril-Hydrochlorothiazide | 12 | $926 | $77 |
| Warfarin | 35 | $883 | $25 |
| Potassium Chloride | 31 | $668 | $22 |
| Amlodipine Besylate | 91 | $617 | $7 |
| Nitrostat | 34 | $577 | $17 |
| Clopidogrel | 35 | $564 | $16 |
| Losartan | 41 | $467 | $11 |
| Furosemide | 51 | $356 | $7 |
| Hydralazine | 37 | $356 | $10 |
| Carvedilol | 49 | $310 | $6 |
| Metoprolol | 31 | $274 | $9 |
| Diltiazem | 11 | $220 | $20 |
| Spironolactone | 18 | $188 | $10 |
| Ramipril | 17 | $170 | $10 |
| Klor-Con 10 | 12 | $154 | $13 |
| Simvastatin | 21 | $147 | $7 |
| Lisinopril | 17 | $146 | $9 |
| Atenolol | 18 | $92 | $5 |
2014: 32 drugs
| Ranexa | 20 | $14,562 | $728 |
| Xarelto | 19 | $6,726 | $354 |
| Diovan | 20 | $6,678 | $334 |
| Crestor | 22 | $6,322 | $287 |
| Zetia | 13 | $5,878 | $452 |
| Pradaxa | 15 | $5,859 | $391 |
| Metoprolol | 75 | $3,174 | $42 |
| Bystolic | 23 | $2,730 | $119 |
| Vytorin | 12 | $2,260 | $188 |
| Atorvastatin | 98 | $2,257 | $23 |
| Micardis | 12 | $1,829 | $152 |
| Pravastatin | 27 | $880 | $33 |
| Clopidogrel | 38 | $874 | $23 |
| Warfarin | 44 | $821 | $19 |
| Amlodipine Besylate | 67 | $617 | $9 |
| Potassium Chloride | 27 | $545 | $20 |
| Carvedilol | 62 | $461 | $7 |
| Isosorbide Mononitrate Er | 19 | $426 | $22 |
| Irbesartan | 16 | $423 | $26 |
| Hydralazine | 12 | $377 | $31 |
| Losartan | 36 | $364 | $10 |
| Ramipril | 21 | $305 | $15 |
| Nitrostat | 24 | $303 | $13 |
| Klor-Con 10 | 18 | $228 | $13 |
| Spironolactone | 12 | $218 | $18 |
| Lisinopril | 22 | $206 | $9 |
| Simvastatin | 21 | $205 | $10 |
| Atenolol | 32 | $202 | $6 |
| Enalapril Maleate | 14 | $199 | $14 |
| Furosemide | 50 | $188 | $4 |
| Metoprolol | 18 | $102 | $6 |
| Benazepril | 14 | $90 | $6 |
2013: 31 drugs
| Pradaxa | 21 | $7,704 | $367 |
| Ranexa | 13 | $6,218 | $478 |
| Zetia | 14 | $5,382 | $384 |
| Diovan | 19 | $4,740 | $249 |
| Atorvastatin | 108 | $4,028 | $37 |
| Lovaza | 16 | $3,341 | $209 |
| Bystolic | 21 | $3,122 | $149 |
| Vytorin | 18 | $2,982 | $166 |
| Benicar | 19 | $2,591 | $136 |
| Metoprolol | 69 | $2,344 | $34 |
| Diltiazem 24hr Er | 12 | $2,093 | $174 |
| Clopidogrel | 28 | $1,780 | $64 |
| Micardis | 12 | $1,677 | $140 |
| Warfarin | 55 | $1,021 | $19 |
| Amlodipine Besylate | 85 | $829 | $10 |
| Sotalol | 17 | $736 | $43 |
| Losartan | 42 | $637 | $15 |
| Isosorbide Mononitrate Er | 23 | $617 | $27 |
| Carvedilol | 56 | $596 | $11 |
| Pravastatin | 17 | $563 | $33 |
| Propafenone | 11 | $447 | $41 |
| Potassium Chloride | 15 | $302 | $20 |
| Simvastatin | 20 | $274 | $14 |
| Nitrostat | 23 | $256 | $11 |
| Atenolol | 27 | $174 | $6 |
| Digox | 18 | $157 | $9 |
| Hydrochlorothiazide | 19 | $143 | $8 |
| Metoprolol | 15 | $99 | $7 |
| Lisinopril | 16 | $86 | $5 |
| Furosemide | 23 | $84 | $4 |
| Benazepril | 11 | $68 | $6 |
Money from drug and device companies
$48 in 2022
| 2022 | 2 | 2 | None | $48 |
| 2020 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Philips Electronics North America | (5050) Ext Holter | $26 | 1 payment
|
| Pfizer | Prevnar 20 | $22 | 1 payment
|
See all 2 published payments
| Philips Electronics North America | Meals · 2022-12-20 | (5050) Ext Holter | $26 |
| Pfizer | Meals · 2022-12-08 | Prevnar 20 | $22 |
See earlier years (2020)
2020: $22
| Medtronic Vascular | Reveal Linq | $22 | 1 payment
|
Professional record
- NPI
- 1871556209
- Licence
- CA A82213California A82213: Current · expires 2027-03-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2001
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 9650 15th Ave Sw Ste 100, Seattle, WA, 98106
- NPI first listed
- 2006-04-07
- NPI last updated
- 2019-02-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 105 N Bascom Ave, San Jose, CA, 95128